Exercise Therapy for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how two exercise types—cardiovascular training (such as running) and resistance training (such as weight lifting)—affect sleep and overall well-being in people with Parkinson's disease. Researchers aim to determine if improved sleep from these exercises also enhances brain health and quality of life. Participants will engage in one type of exercise for 12 weeks, twice a week, with evaluations conducted before and after the program. This trial suits individuals with mild to moderate Parkinson's who experience sleep difficulties and maintain a stable medication routine. As an unphased trial, it offers a unique opportunity to contribute to understanding how exercise can improve life quality for those with Parkinson's.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that you have been on a stable dosage of medication for the past month.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both cardiovascular and resistance exercises are generally safe for people with Parkinson's disease (PD). Aerobic exercises, including cardiovascular workouts, can improve balance, walking, and motor skills in individuals with PD. They also help lower the risk of heart disease and can increase life expectancy. Some research suggests that high-intensity aerobic exercise might protect brain cells that produce dopamine, which is important for movement.
Resistance training is also beneficial. Studies indicate it increases muscle strength and aids mobility. It can improve quality of life and help with issues like "freezing of gait," when someone feels stuck and unable to move.
Both types of exercise have been extensively studied and are well-tolerated. No major safety concerns have been reported for either type in people with Parkinson's disease. Participants usually manage these exercises well, making them a safe option for those considering joining a trial.12345Why are researchers excited about this trial?
Researchers are excited about exploring exercise therapy for Parkinson's Disease because it taps into the body's natural ability to improve its own function without medication. Unlike standard treatments that primarily rely on medication to manage symptoms, cardiovascular and resistance training focus on enhancing physical fitness, which could lead to improved mobility and strength. Cardiovascular training ramps up gradually to a vigorous intensity, potentially boosting heart health and endurance, while resistance training strengthens muscles through a systematic increase in intensity. These methods offer a non-invasive, holistic approach that might complement existing treatments and improve quality of life for patients.
What evidence suggests that this trial's treatments could be effective for Parkinson's disease?
This trial will compare two types of exercise therapy for Parkinson's disease: cardiovascular training and resistance training. Research has shown that aerobic exercise, such as cardiovascular training, can improve heart health and reduce the risk of heart disease in people with Parkinson's. Regular aerobic exercise may also slow the progression of Parkinson's and protect dopamine-producing brain cells, which are often lost in the disease. Meanwhile, resistance training has significantly increased muscle strength, by 15% to 83.2%, in people with Parkinson's. This type of exercise can also enhance coordination and balance, making everyday movements easier. Both exercise types improve movement-related symptoms in Parkinson's, making them promising therapy options.23678
Are You a Good Fit for This Trial?
This trial is for people with mild to moderate Parkinson's Disease who have poor sleep quality but are on stable medication. They should not be in other drug/exercise trials, have severe untreated sleep apnea, dementia or conditions that prevent exercise. A score >18 on PDSS-2 and <21 on MoCA excludes them.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants perform either cardiovascular training or resistance training for 12 weeks, at least two times per week
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cardiovascular Training
- Resistance Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University
Lead Sponsor
Jewish Rehabilitation Hospital
Collaborator